• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pluronic L-81 ameliorates diabetic symptoms in db/db mice through transcriptional regulation of microsomal triglyceride transfer protein.普朗尼克L-81通过微粒体甘油三酯转运蛋白的转录调控改善db/db小鼠的糖尿病症状。
World J Gastroenterol. 2009 Jun 28;15(24):2987-94. doi: 10.3748/wjg.15.2987.
2
Activation of peroxisome proliferator-activated receptor alpha increases the expression and activity of microsomal triglyceride transfer protein in the liver.过氧化物酶体增殖物激活受体α的激活增加了肝脏中微粒体甘油三酯转运蛋白的表达和活性。
J Biol Chem. 2005 Jan 14;280(2):1224-9. doi: 10.1074/jbc.M412107200. Epub 2004 Nov 9.
3
Differential modulatory effects of rosiglitazone and pioglitazone on white adipose tissue in db/db mice.罗格列酮和吡格列酮对 db/db 小鼠白色脂肪组织的差异调节作用。
Life Sci. 2010 Sep 25;87(13-14):405-10. doi: 10.1016/j.lfs.2010.08.002. Epub 2010 Aug 17.
4
Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice.在肥胖糖尿病小鼠中,微粒体甘油三酯转移蛋白的肝脏表达及富含甘油三酯脂蛋白的体内分泌增加。
Diabetes. 2002 Apr;51(4):1233-9. doi: 10.2337/diabetes.51.4.1233.
5
Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.脑源性神经营养因子与噻唑烷二酮类药物对肥胖糖尿病小鼠抗糖尿病作用的比较
Diabetes Obes Metab. 2007 Nov;9(6):879-88. doi: 10.1111/j.1463-1326.2006.00675.x.
6
Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice.二肽基肽酶IV抑制剂与低剂量噻唑烷二酮的联合应用:db/db小鼠的临床前疗效与安全性
Life Sci. 2007 Jun 13;81(1):72-9. doi: 10.1016/j.lfs.2007.04.026. Epub 2007 May 1.
7
Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.噻格列酮,一种新型降糖药。I. 对ob/ob和db/db小鼠、糖尿病中国仓鼠以及正常和链脲佐菌素诱导糖尿病大鼠的研究。
Diabetes. 1983 Sep;32(9):830-8. doi: 10.2337/diab.32.9.830.
8
Octreotide promotes weight loss via suppression of intestinal MTP and apoB48 expression in diet-induced obesity rats.奥曲肽通过抑制饮食诱导肥胖大鼠肠 MTP 和 apoB48 的表达来促进体重减轻。
Nutrition. 2013 Oct;29(10):1259-65. doi: 10.1016/j.nut.2013.01.013. Epub 2013 Jul 30.
9
Effect of Chinese prescription Kangen-karyu on lipid metabolism in type 2 diabetic db/db mice.中文处方抗糖丸对 2 型糖尿病 db/db 小鼠脂代谢的影响。
J Ethnopharmacol. 2010 Jun 16;129(3):299-305. doi: 10.1016/j.jep.2010.03.032. Epub 2010 Apr 2.
10
Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.非诺贝特与罗格列酮联合应用对肥胖 2 型糖尿病小鼠胰岛素抵抗的协同改善作用。
Arch Pharm Res. 2011 Apr;34(4):615-24. doi: 10.1007/s12272-011-0412-9. Epub 2011 May 5.

引用本文的文献

1
Six weeks' sebacic acid supplementation improves fasting plasma glucose, HbA1c and glucose tolerance in db/db mice.六星期癸二酸补充可改善 db/db 小鼠的空腹血糖、HbA1c 和葡萄糖耐量。
Diabetes Obes Metab. 2010 Dec;12(12):1120-6. doi: 10.1111/j.1463-1326.2010.01308.x.

本文引用的文献

1
Hepatocyte nuclear factor 1 binding element within the promoter of microsomal triglyceride transfer protein (MTTP) gene is crucial for MTTP basal expression and insulin responsiveness.
J Mol Endocrinol. 2008 Oct;41(4):229-38. doi: 10.1677/JME-08-0080. Epub 2008 Aug 12.
2
MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?
Expert Opin Ther Targets. 2007 Feb;11(2):181-9. doi: 10.1517/14728222.11.2.181.
3
Pluronic L81 enhances triacylglycerol accumulation in the cytosol and inhibits chylomicron secretion.普朗尼克L81增强了细胞质中三酰甘油的积累,并抑制乳糜微粒的分泌。
J Lipid Res. 2006 Nov;47(11):2422-32. doi: 10.1194/jlr.M600211-JLR200. Epub 2006 Aug 7.
4
Adiposity signals, genetic and body weight regulation in humans.人体中的肥胖信号、基因与体重调节
Diabetes Metab. 2004 Jun;30(3):215-27. doi: 10.1016/s1262-3636(07)70112-x.
5
Control of pancreas and liver gene expression by HNF transcription factors.肝细胞核因子转录因子对胰腺和肝脏基因表达的调控
Science. 2004 Feb 27;303(5662):1378-81. doi: 10.1126/science.1089769.
6
Obesity wars: molecular progress confronts an expanding epidemic.肥胖之战:分子层面的进展遭遇不断蔓延的流行病。
Cell. 2004 Jan 23;116(2):337-50. doi: 10.1016/s0092-8674(03)01081-x.
7
Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors.综述:脂质代谢、代谢性疾病与过氧化物酶体增殖物激活受体
Endocrinology. 2003 Jun;144(6):2201-7. doi: 10.1210/en.2003-0288.
8
Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38.
Diabetes. 2003 May;52(5):1073-80. doi: 10.2337/diabetes.52.5.1073.
9
The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones.胰岛素抵抗中的脂肪细胞:关键分子及噻唑烷二酮类药物的影响
Trends Endocrinol Metab. 2003 Apr;14(3):137-45. doi: 10.1016/s1043-2760(03)00024-9.
10
Pluronic block copolymers for overcoming drug resistance in cancer.用于克服癌症耐药性的普朗尼克嵌段共聚物
Adv Drug Deliv Rev. 2002 Sep 13;54(5):759-79. doi: 10.1016/s0169-409x(02)00047-9.

普朗尼克L-81通过微粒体甘油三酯转运蛋白的转录调控改善db/db小鼠的糖尿病症状。

Pluronic L-81 ameliorates diabetic symptoms in db/db mice through transcriptional regulation of microsomal triglyceride transfer protein.

作者信息

Au Wo-Shing, Lu Li-Wei, Tam Sidney, Ko Otis King Hung, Chow Billy K C, He Ming-Liang, Ng Samuel S, Yeung Chung-Man, Liu Ching-Chiu, Kung Hsiang-Fu, Lin Marie C

机构信息

Department of Chemistry, Institute of Molecular Technology for Drug Discovery and Synthesis, The University of Hong Kong, Kadoorie Biological Science Building, Hong Kong, China.

出版信息

World J Gastroenterol. 2009 Jun 28;15(24):2987-94. doi: 10.3748/wjg.15.2987.

DOI:10.3748/wjg.15.2987
PMID:19554651
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2702106/
Abstract

AIM

To test whether oral L-81 treatment could improve the condition of mice with diabetes and to investigate how L-81 regulates microsomal triglyceride transfer protein (MTP) activity in the liver.

METHODS

Genetically diabetic (db/db) mice were fed on chow supplemented with or without L-81 for 4 wk. The body weight, plasma glucose level, plasma lipid profile, and adipocyte volume of the db/db mice were assessed after treatment. Toxicity of L-81 was also evaluated. To understand the molecular mechanism, HepG2 cells were treated with L-81 and the effects on apolipoprotein B (apoB) secretion and mRNA level of the MTP gene were assessed.

RESULTS

Treatment of db/db mice with L-81 significantly reduced and nearly normalized their body weight, hyperphagia and polydipsia. L-81 also markedly decreased the fasting plasma glucose level, improved glucose tolerance, and attenuated the elevated levels of plasma cholesterol and triglyceride. At the effective dosage, little toxicity was observed. Treatment of HepG2 cells with L-81 not only inhibited apoB secretion, but also significantly decreased the mRNA level of the MTP gene. Similar to the action of insulin, L-81 exerted its effect on the MTP promoter.

CONCLUSION

L-81 represents a promising candidate in the development of a selective insulin-mimetic molecule and an anti-diabetic agent.

摘要

目的

检测口服L - 81治疗是否能改善糖尿病小鼠的病情,并研究L - 81如何调节肝脏微粒体甘油三酯转运蛋白(MTP)的活性。

方法

给遗传性糖尿病(db/db)小鼠喂食添加或不添加L - 81的普通饲料4周。治疗后评估db/db小鼠的体重、血糖水平、血脂谱和脂肪细胞体积。还评估了L - 81的毒性。为了解分子机制,用L - 81处理HepG2细胞,并评估其对载脂蛋白B(apoB)分泌和MTP基因mRNA水平的影响。

结果

用L - 81治疗db/db小鼠可显著降低其体重、多食和多饮,并使其接近正常水平。L - 81还显著降低空腹血糖水平,改善糖耐量,并减轻血浆胆固醇和甘油三酯水平的升高。在有效剂量下,未观察到明显毒性。用L - 81处理HepG2细胞不仅抑制apoB分泌,还显著降低MTP基因的mRNA水平。与胰岛素的作用相似,L - 81对MTP启动子发挥作用。

结论

L - 81是开发选择性胰岛素模拟分子和抗糖尿病药物的有前景的候选物。